← All Sponsors
SPONSOR

Fulgent Pharma LLC.

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Advanced Solid Tumors
NCT06694480 Phase 1
Recruiting

Study of FID-022 in Participants With Advanced Solid Tumors

Advanced Solid Tumors
United States View Trial →